Drug Repurposing of Lactoferrin Combination in a Nanodrug Delivery System to Combat Severe Acute Respiratory Syndrome Coronavirus-2 Infection
A drug repurposing approach for Food and Drug Administration (FDA)-approved drugs and preclinical entity by using cheminformatics and chemical transformational method, with the objective of discovering safer novel potent inhibitors that are selective for COVID-19, is reported. We examined the action...
Main Authors: | Assem Barakat, Abdullah Mohammed Al-Majid, Gehad Lotfy, Mohamed Ali, Ahmed Mostafa, Yaseen A.M.M. Elshaier |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2021-08-01
|
Series: | Dr. Sulaiman Al Habib Medical Journal |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125960011/view |
Similar Items
-
Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
by: Eduarda Ribeiro, et al.
Published: (2023-03-01) -
Antimicrobial activity of lactoferrin and lactoferrin derived peptides /
by: 485757 Jenssen, Havard
Published: (c200) -
Efficiently targeted therapy of glioblastoma xenograft via multifunctional biomimetic nanodrugs
by: Zhipeng Yao, et al.
Published: (2022-12-01) -
A Novel Experimental Approach to Understand the Transport of Nanodrugs
by: Soubantika Palchoudhury, et al.
Published: (2023-08-01) -
Supramolecular self-assembly of EGCG-selenomethionine nanodrug for treating osteoarthritis
by: Haichao Yu, et al.
Published: (2024-02-01)